Incremental innovation in medication

Ojer Pharma’s product portfolio consists of around twenty incremental innovation products in the area of dermatology, and also a range of dermocosmetic products. The originality of the way in which our medicines are developed lies in creating innovative associations of existing active ingredients, which then attack the skin condition from an equally innovative angle. Our products seek the simultaneous treatment of aetiological (causes) and symptomatological (associated symptoms) aspects of the illness.

We have set up ongoing R&D into our specialities with the aim of adapting to pharmaceutical demand in the market. In other words, we set out to identify existing treatment ‘niches’ to create dermatological solutions that cover patients’ needs.

Our medicine portfolio for health self-help is specialised in specific points of treatment. We deal with a range of skin conditions of different seriousness, from the mildest to those that are most serious, for example, pressure ulcers.